3F88 image
Entry Detail
PDB ID:
3F88
Keywords:
Title:
glycogen synthase Kinase 3beta inhibitor complex
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2008-11-11
Release Date:
2009-03-10
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.28
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Glycogen synthase kinase-3 beta
Chain IDs:A, B
Chain Length:349
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PTR A TYR O-PHOSPHOTYROSINE
Primary Citation
Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
Bioorg.Med.Chem. 17 2017 2029 (2009)
PMID: 19200745 DOI: 10.1016/j.bmc.2009.01.019

Abstact

Glycogen synthase kinase-3beta (GSK-3beta) is implicated in abnormal hyperphosphorylation of tau protein and its inhibitors are expected to be a promising therapeutic agents for the treatment of Alzheimer's disease. Here we report design, synthesis and structure-activity relationships of a novel series of oxadiazole derivatives as GSK-3beta inhibitors. Among these inhibitors, compound 20x showed highly selective and potent GSK-3beta inhibitory activity in vitro and its binding mode was determined by obtaining the X-ray co-crystal structure of 20x and GSK-3beta.

Legend

Protein

Chemical

Disease

Primary Citation of related structures